FOXP3 and neoplasm: All tested NeoAg-specific TCRs, including the lowest affinity TCR identified as being expressed solely by a single FoxP3+ cell, were capable of mediating tumor clearance to a comparable extent and were found within the tumor-draining lymph nodes at similar frequencies independent of the functional subset from which the TCR was identified, TCR affinity, or transduction efficiency.